Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FES PET for Prognosis and Response in Breast Cancer
NCT03544762Phase 3Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Sep 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluoroestradiol f 18 in breast cancer, sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
fluoroestradiol f 18
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03544762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03544762.